Hong Kong stock Shanghai Fosun Pharmaceutical rose more than...
Hong Kong stock Shanghai Fosun Pharmaceutical rose more than 14%.
BioNTech has completed a phase II trial of the Fubitai vaccine in China, Reuters reported.
$FOSUN PHARMA(02196.HK$
BioNTech has completed a phase II trial of the Fubitai vaccine in China, Reuters reported.
$FOSUN PHARMA(02196.HK$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Twitter@Sino_Market | Realtime Chinese market info provider.
9229Followers
4Following
8777Visitors
Follow